Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $23.0 million, down from $28.0 million in Q3 2025 and $25.1 million in Q4 2024 [4] - Non-GAAP gross margin in Q4 was 21.5%, compared to 22.6% in Q3 2025 and 18.0% in Q4 2024 [5] - GAAP net loss in Q4 was $3.6 million, or $0.08 per share, compared to a net loss of $1.9 million, or $0.04 per share in Q3 2025 [8][9] - Cash, cash equivalents, and investments increased by $97.2 million to $128.4 million as of December 31, primarily due to a public offering [9] Business Line Data and Key Metrics Changes - Revenue from Indium Phosphide was $8.0 million, primarily from data center applications, while Gallium Arsenide generated $7.0 million [4] - Revenue from consolidated raw material joint ventures was $7.6 million in Q4 2025 [4] - Operating expenses increased to $7.8 million in Q4 from $6.5 million in Q3 2025 [6] Market Data and Key Metrics Changes - Revenue from Asia Pacific accounted for 81.5%, Europe 17.5%, and North America 1% in Q4 2025 [4] - Revenue related to the data center market in China is expected to grow by more than 60% in Q1 2026 compared to Q4 2025 [17] Company Strategy and Development Direction - The company plans to list its subsidiary, Tongmei, on the STAR Market in Shanghai, focusing on the growing demand for indium phosphide substrates driven by AI infrastructure [10] - AXT is expanding its capacity, aiming to double it by the end of 2026, with a focus on six-inch indium phosphide products [18][53] - The company is actively engaging with customers to understand their long-term requirements and align expansion plans globally [18] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment over the number of export permits received in Q4 but noted improvements in Q1 [14] - The company expects sequential revenue growth in Q1, driven by indium phosphide demand for AI data centers [14] - Management highlighted the importance of obtaining export permits as a significant factor for growth [24] Other Important Information - The company has added approximately 25% more capacity and plans to double capacity from Q4 2025 levels by the end of 2026 [18][53] - The raw material business showed growth, with subsidiaries refining high-quality indium and manufacturing PBN crucibles [21] Q&A Session Summary Question: Revenue number for the quarter - The revenue number for Q4 2025 is $23.0 million, with a potential upside if more permits are received [29][30] Question: Insights on the licensing process - The licensing process has become less predictable, with some permits denied but with instructions for resubmission [38][41] Question: Backlog and customer demand - The backlog has increased to over $60 million, with customers ordering further out due to increasing demand forecasts [46][50] Question: Capacity additions and CapEx requirements - The company plans to double capacity by the end of 2026, requiring approximately $30 million for the initial phase [53] Question: Demand and shipment capabilities - If permits were not a restriction, the company could potentially ship around $20 million worth of indium phosphide [88]

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $28.0 million, up from $18.0 million in Q2 2025 and $23.6 million in Q3 2024, representing a 56% sequential growth and 18% year-over-year growth [5][12] - Non-GAAP gross margin improved to 22.4% in Q3 2025, compared to 8.2% in Q2 2025 and 24.3% in Q3 2024 [6][9] - Non-GAAP operating loss improved to $0.384 million in Q3 2025 from $6.1 million in Q2 2025 and $2.6 million in Q3 2024 [8][9] - Non-GAAP net loss was $1.2 million, or $0.03 per share, compared to a loss of $6.4 million, or $0.15 per share, in Q2 2025 [9][10] Business Line Data and Key Metrics Changes - Indium Phosphide revenue reached $13.1 million, primarily driven by data center and passive optical network applications [5][12] - Gallium Arsenide revenue was $7.5 million, while Germanium substrates generated $0.64 million [5] - Revenue from consolidated raw material joint ventures was $6.7 million, consistent with the prior quarter [5][18] Market Data and Key Metrics Changes - Revenue from Asia-Pacific accounted for 87%, Europe for 12%, and North America for 1% in Q3 2025 [5] - Indium Phosphide order backlog exceeded $49 million, indicating strong demand from data center applications globally [12][20] Company Strategy and Development Direction - The company is focused on increasing manufacturing capacity and efficiency to meet growing demand, particularly for Indium Phosphide substrates [16][19] - Plans to list subsidiary Tongmei on the STAR Market in Shanghai are ongoing, with the IPO application kept current despite a selective listing environment [10] - The company aims to drive gross margin improvement and operational efficiency while managing export permit processes effectively [19][24] Management's Comments on Operating Environment and Future Outlook - Management noted a strong uptick in Indium Phosphide demand due to AI infrastructure buildout and data center expansions [12][16] - The geopolitical environment is dynamic, affecting export permit processes, which remain a significant gating factor for growth [20][21] - The company expects revenue in Q4 2025 to be in the range of $27 to $30 million, contingent on the timing of export permits [22][24] Other Important Information - Cash and cash equivalents decreased by $3.9 million to $31.2 million as of September 30, 2025, with accounts receivable increasing by $11 million [9][10] - The company is actively engaging with new Tier 1 customers to qualify materials into their supply chains [14][16] Q&A Session Summary Question: Customer behavior regarding longer-term orders and permits - Management explained that the $49 million backlog includes orders from customers with existing permits and those still in the permit phase, indicating confidence in future permit approvals [27][28] Question: Profitability and cost structure changes - Management acknowledged that improving gross margins is essential, focusing on product mix and manufacturing efficiencies to return to previous profitability levels [37][39] Question: Indium Phosphide demand from domestic vs. overseas customers - Approximately 40% of Indium Phosphide business is from domestic Chinese customers, with significant demand driven by AI data center growth in the U.S. [40][42] Question: Capacity and backlog dynamics - The backlog has more than doubled compared to the previous quarter, with customers placing orders for immediate shipment upon receiving permits [46][47] Question: Competitor capacity increases and shipping capabilities - Management reiterated that the ability to ship is contingent on obtaining export permits, which currently take about 60 business days to process [87][88]